To find out the dose of intranasal Dexmedetomidine to provide sedation in children undergoing MRI .
Phase 4
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2024/01/061153
- Lead Sponsor
- Department of Anaesthesia and Intensive Care
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Children of either gender aged 1 to 5 years of age
-ASA status I, II
-undergoing Non Contrast MRI BRAIN
Exclusion Criteria
-Refusal of parentsguardian to give consent
-Recent upper respiratory tract infection(URTI)(less than 2 weeks)
-Non fasted
-Nasal deformity
-Anticapated difficult airway
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the 50% and 95% effective dose of intranasal dexmedetomidine for effective sedation in Indian population undergoing MRI.Timepoint: every five minutes after sedation till FASTTRACK >12
- Secondary Outcome Measures
Name Time Method -To investigate the efficacy of single shot intranasal dexmedetomidine for IV cannulation <br/ ><br>-To determine safety profile of intranasal dexmedetomidine for paediatric MRI. <br/ ><br>Timepoint: every five minutes after sedation till FASTTRACK >12